Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bensemain F et al. - Induction of OTC expression in AD process and a potential implication of OTC as genetic determinant of AD. This study suggests that disturbance of ammonia metabolism or NO synthesis may be potentially involved in the pathogenesis of AD and this might offer novel therapeutic approaches.

Related Articles

Does Diabetes Speed Up Memory Loss In Alzheimers Disease?
ScienceDaily, 10/28/09    Relevance Score: 70%

Activated astrocytes: a therapeutic target in Alzheimer's disease?
Expert Review of Neurotherapeutics, 11/19/09    Relevance Score: 69%

High Blood Pressure Likely in Alzheimers Offspring
MedLinePlus, 11/04/09    Relevance Score: 69%

New neuroimaging analysis technique identifies impact of Alzheimer's disease gene in healthy brains
EurekAlert, 11/18/09    Relevance Score: 68%

Protective Role For Copper In Alzheimers Disease
ScienceDaily, 10/14/09    Relevance Score: 68%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address